98 related articles for article (PubMed ID: 19125411)
1. Depletion of CD4(+)CD25(+) T cells exacerbates experimental autoimmune encephalomyelitis induced by mouse, but not rat, antigens.
Akirav EM; Bergman CM; Hill M; Ruddle NH
J Neurosci Res; 2009 Nov; 87(15):3511-9. PubMed ID: 19125411
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.
Buhler LA; Samara R; Guzman E; Wilson CL; Krizanac-Bengez L; Janigro D; Ethell DW
BMC Neurosci; 2009 Mar; 10():17. PubMed ID: 19267908
[TBL] [Abstract][Full Text] [Related]
3. Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity.
Gokhale AS; Gangaplara A; Lopez-Occasio M; Thornton AM; Shevach EM
J Autoimmun; 2019 Dec; 105():102300. PubMed ID: 31296356
[TBL] [Abstract][Full Text] [Related]
4. The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Rouse M; Nagarkatti M; Nagarkatti PS
Immunobiology; 2013 Apr; 218(4):674-82. PubMed ID: 22954711
[TBL] [Abstract][Full Text] [Related]
5. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis.
Kivisäkk P; Imitola J; Rasmussen S; Elyaman W; Zhu B; Ransohoff RM; Khoury SJ
Ann Neurol; 2009 Apr; 65(4):457-69. PubMed ID: 18496841
[TBL] [Abstract][Full Text] [Related]
6. Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues.
Lin Y; Sakuraba S; Massilamany C; Reddy J; Tanaka Y; Miyake S; Yamamura T
J Autoimmun; 2023 Nov; 140():103094. PubMed ID: 37716077
[TBL] [Abstract][Full Text] [Related]
7. Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells.
Gabrysová L; Wraith DC
Eur J Immunol; 2010 May; 40(5):1386-95. PubMed ID: 20162554
[TBL] [Abstract][Full Text] [Related]
8. Getting to the crux of the matter: IL-23 and Th17 cell accumulation in the CNS.
Segal BM
Eur J Immunol; 2009 Jul; 39(7):1713-5. PubMed ID: 19582738
[TBL] [Abstract][Full Text] [Related]
9. Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates.
Pearson RM; Casey LM; Hughes KR; Wang LZ; North MG; Getts DR; Miller SD; Shea LD
Mol Ther; 2017 Jul; 25(7):1655-1664. PubMed ID: 28479234
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of autoimmune neuro-inflammation in mice cured from blood-stage Plasmodium berghei infection.
Thomé R; Bombeiro AL; Issayama LK; Rapôso C; Lopes SC; da Costa TA; Di Gangi R; Ferreira IT; Longhini AL; Oliveira AL; da Cruz Höfling MA; Costa FT; Verinaud L
PLoS One; 2014; 9(10):e110739. PubMed ID: 25329161
[TBL] [Abstract][Full Text] [Related]
11. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model.
Najafian N; Chitnis T; Salama AD; Zhu B; Benou C; Yuan X; Clarkson MR; Sayegh MH; Khoury SJ
J Clin Invest; 2003 Oct; 112(7):1037-48. PubMed ID: 14523041
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune T cell responses in the central nervous system.
Goverman J
Nat Rev Immunol; 2009 Jun; 9(6):393-407. PubMed ID: 19444307
[TBL] [Abstract][Full Text] [Related]
13. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.
Yoshizaki A; Miyagaki T; DiLillo DJ; Matsushita T; Horikawa M; Kountikov EI; Spolski R; Poe JC; Leonard WJ; Tedder TF
Nature; 2012 Nov; 491(7423):264-8. PubMed ID: 23064231
[TBL] [Abstract][Full Text] [Related]
14. Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored?
Vandenbark AA; Offner H
Immunology; 2008 Sep; 125(1):1-13. PubMed ID: 18798915
[TBL] [Abstract][Full Text] [Related]
15. Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice.
Stern JN; Keskin DB; Zhang H; Lv H; Kato Z; Strominger JL
Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5172-6. PubMed ID: 18362339
[TBL] [Abstract][Full Text] [Related]
16. Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota.
Cignarella F; Cantoni C; Ghezzi L; Salter A; Dorsett Y; Chen L; Phillips D; Weinstock GM; Fontana L; Cross AH; Zhou Y; Piccio L
Cell Metab; 2018 Jun; 27(6):1222-1235.e6. PubMed ID: 29874567
[TBL] [Abstract][Full Text] [Related]
17. Improving biomarker identification with better designs and reporting.
Pepe MS; Feng Z
Clin Chem; 2011 Aug; 57(8):1093-5. PubMed ID: 21666069
[No Abstract] [Full Text] [Related]
18. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage.
O'Garra A; Vieira PL; Vieira P; Goldfeld AE
J Clin Invest; 2004 Nov; 114(10):1372-8. PubMed ID: 15545984
[TBL] [Abstract][Full Text] [Related]
19. Self and non-self discrimination is needed for the existence rather than deletion of autoimmunity: the role of regulatory T cells in protective autoimmunity.
Schwartz M; Kipnis J
Cell Mol Life Sci; 2004 Sep; 61(18):2285-9. PubMed ID: 15378200
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Purine Metabolism-Potential Target in Multiple Sclerosis.
Laketa D; Lavrnja I
Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38499905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
